Drug Shortage Report for ATARAX
Report ID | 194896 |
Drug Identification Number | 00024694 |
Brand name | ATARAX |
Common or Proper name | Atarax |
Company Name | SEARCHLIGHT PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROXYZINE HYDROCHLORIDE |
Strength(s) | 10MG |
Dosage form(s) | SYRUP |
Route of administration | ORAL ORAL |
Packaging size | 473ml |
ATC code | N05BB |
ATC description | ANXIOLYTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-06-14 |
Actual start date | 2023-06-14 |
Estimated end date | 2023-07-21 |
Actual end date | 2023-07-14 |
Shortage status | Resolved |
Updated date | 2023-07-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2023-07-15 | English | Compare |
v8 | 2023-07-14 | French | Compare |
v7 | 2023-07-14 | English | Compare |
v6 | 2023-07-14 | French | Compare |
v5 | 2023-07-14 | English | Compare |
v4 | 2023-07-14 | English | Compare |
v3 | 2023-06-15 | English | Compare |
v2 | 2023-06-14 | French | Compare |
v1 | 2023-06-14 | English | Compare |
Showing 1 to 9 of 9